Product Images Memantine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Memantine Hydrochloride NDC 0527-1222 by Lannett Company, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

memantine-hcl-molec-struc - memantine hydrochloride tablets 1

memantine-hcl-molec-struc - memantine hydrochloride tablets 1

5 mg 60 count bottle label - memantine hydrochloride tablets 10

5 mg 60 count bottle label - memantine hydrochloride tablets 10

Each tablet contains 5 mg of memantine hydrochloride, USP. Please check package insert for dosing and prescribing information. The tablets are child-resistant with a dosage of 5mg. Store at 25°C (77°F) with excursions permitted for 15°C to 30°C (59°F to 86°F). The tablets are made by Lonnett Company, Inc. in Philadelphia, PA 19154.*

10 mg 60 count bottle label - memantine hydrochloride tablets 11

10 mg 60 count bottle label - memantine hydrochloride tablets 11

fig1 - memantine hydrochloride tablets 2

fig1 - memantine hydrochloride tablets 2

fig2 - memantine hydrochloride tablets 3

fig2 - memantine hydrochloride tablets 3

fig3 - memantine hydrochloride tablets 4

fig3 - memantine hydrochloride tablets 4

fig4 - memantine hydrochloride tablets 5

fig4 - memantine hydrochloride tablets 5

This appears to be a graph or chart with two lines representing the cumulative percentage of patients taking either a placebo or a medication called memantine. The y-axis is not visible, but the x-axis appears to represent a measurement called "SIB Change from Baseline". Without more information or context, it is difficult to provide a more detailed description or interpretation of the graph.*

fig5 - memantine hydrochloride tablets 6

fig5 - memantine hydrochloride tablets 6

fig6 - memantine hydrochloride tablets 7

fig6 - memantine hydrochloride tablets 7

fig7 - memantine hydrochloride tablets 8

fig7 - memantine hydrochloride tablets 8

This appears to be a table showing the mean change from baseline in SIB score for a clinical study, with two treatment groups (Placebo/Donepezil and Memantine/Donepezil) and a measurement at week 34. The table also includes categories for clinical improvement and decline.*

fig8 - memantine hydrochloride tablets 9

fig8 - memantine hydrochloride tablets 9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.